Cavernous Sinus Dissection and Bleeding in Meningiomas

NCT ID: NCT02863484

Last Updated: 2016-08-11

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

PHASE4

Total Enrollment

120 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-05-31

Study Completion Date

2016-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The blood loss will be compared in middle fossa meningiomas which will receive pealing of the outer layer of the lateral wall of the cavernous sinus and those which will not revive pealing before the dura is opened

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Cases with middle fossa meningiomas will be randomised to one of two surgical techniques. The first technique will involve pealing of the outer layer of the lateral wall of the cavernous sinus before the dura is opened and the tumour attacked, and the second group of cases will be operated by a standard technique, where the tumour will be directly attacked with out pealing of the outer layer of the lateral wall of the cavernous sinus. Blood loss will be monitored in each case by calculating the amount of blood in the suction container and subtracting it from the amount of fluids used for irrigation during surgery. The number of cotton patties and dressings will be also counted with each case as well as the number of gauzes used. The pre-operative complete blood picture will be documented particularly the haemoglobin , hematocrits and others. The same lab data will be also monitored after surgery. The amount of blood transfusion required will also be calculated in each case.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Meningiomas of the Middle Cranial Fossa

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Conventional surgery intra-dural

This arm will be surgically operated by direct attack of the tumour after opening the dura

Group Type ACTIVE_COMPARATOR

surgery

Intervention Type OTHER

pealing of the outer layer of the cavernous sinus

Pealing surgery extra-dural

This arm the pealing of the outer layer of the lateral wall of the cavernous sinus will be done before the dura is opened. After the pealing is completed, the middle meningeal artery will be divided at the foramen spinosum. Then, the dura will be opened and the tumour attacked.

Group Type EXPERIMENTAL

surgery

Intervention Type OTHER

pealing of the outer layer of the cavernous sinus

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

surgery

pealing of the outer layer of the cavernous sinus

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Meningiomas of the middle cranial fossa

Exclusion Criteria

* Meningiomas outside the middle cranial fossa
Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Kasr El Aini Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Ahmed Hegazy

Dr.

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Ahmed Hegazy, MD

Role: PRINCIPAL_INVESTIGATOR

Professor of neurosurgery, faculty of medicine, Cairo University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Kasralainy medical college, Cairo University

Cairo, Greater Cairo, Egypt

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Ahmed A Hegazy, MD

Role: CONTACT

01002155090

Noha Asem, MD

Role: CONTACT

01003657120

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Ahmed Hegazy, MD

Role: primary

01002155090

Noha Asem, MD

Role: backup

01003657120

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

N-44-2016

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.